These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 32646896)

  • 1. Adding an important piece to the pulmonary vascular resistance puzzle in pulmonary arterial hypertension.
    Maron BA; Humbert M
    Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32646896
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical application of pulmonary vascular resistance in patients with pulmonary arterial hypertension.
    Deng J
    J Cardiothorac Surg; 2021 Oct; 16(1):311. PubMed ID: 34670595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary Vascular Resistance in Pulmonary Arterial Hypertension: La Pièce de Résistance?
    Weatherald J; Boucly A; Savale L; Jaïs X; Montani D; Humbert M; Sitbon O
    Am J Respir Crit Care Med; 2021 Feb; 203(4):524-525. PubMed ID: 33105080
    [No Abstract]   [Full Text] [Related]  

  • 4. Reply to Weatherald
    Badagliacca R; D'Alto M; Ghio S; Vizza CD; Naeije R
    Am J Respir Crit Care Med; 2021 Feb; 203(4):525-526. PubMed ID: 33105086
    [No Abstract]   [Full Text] [Related]  

  • 5. Assessing the cancer hypothesis of pulmonary arterial hypertension: the devil is in the detail.
    Frump AL; Lai YC; Lahm T
    Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1140-L1141. PubMed ID: 32186392
    [No Abstract]   [Full Text] [Related]  

  • 6. Multilevel omics: A next step on the way to understanding pulmonary arterial hypertension?
    Aman J; Hovingh GK
    Thorax; 2019 Apr; 74(4):317-318. PubMed ID: 30679265
    [No Abstract]   [Full Text] [Related]  

  • 7. Deconstructing the Melting Pot in Pulmonary Arterial Hypertension.
    Austin ED; Hamid R
    Am J Respir Crit Care Med; 2020 Jun; 201(11):1329-1331. PubMed ID: 32053755
    [No Abstract]   [Full Text] [Related]  

  • 8. Checkpoint Kinase 1 Promotes the Development of Pulmonary Arterial Hypertension.
    Satoh K; Kikuchi N; Kurosawa R; Shimokawa H
    Arterioscler Thromb Vasc Biol; 2019 Aug; 39(8):1504-1506. PubMed ID: 31339778
    [No Abstract]   [Full Text] [Related]  

  • 9. A Novel Peptide for Immunomodulation in Pulmonary Arterial Hypertension.
    Grinnan D; Farkas L
    Am J Respir Crit Care Med; 2019 Jun; 199(12):1460-1461. PubMed ID: 30973752
    [No Abstract]   [Full Text] [Related]  

  • 10. Real-World Data for Pulmonary Arterial Hypertension.
    Elliott CG
    Chest; 2019 Apr; 155(4):653-654. PubMed ID: 30955564
    [No Abstract]   [Full Text] [Related]  

  • 11. "Rehab for all!" Is it too early in pulmonary arterial hypertension?
    Bertoletti L; Bouvaist H; Tromeur C; Bezzeghoud S; Dauphin C; Enache I; Bourdin A; Seronde MF; Montani D; Turquier S; Pison C; ;
    Eur Respir J; 2019 Nov; 54(5):. PubMed ID: 31699779
    [No Abstract]   [Full Text] [Related]  

  • 12. Request to "Update" the 2019 Update of Guidelines for Management of Pulmonary Arterial Hypertension.
    Durrani J; Toor A
    Chest; 2019 Jul; 156(1):187. PubMed ID: 31279369
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnosis of idiopathic pulmonary arterial hypertension by "3P" algorithm].
    Fan FL; Zhang SL; Song Q; Xie XG; Zhang YP; Huo XW; Zou YL
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Jul; 48(7):621-625. PubMed ID: 32842275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Janus Faces of Bone Morphogenetic Protein 9 in Pulmonary Arterial Hypertension.
    Ormiston ML; Godoy RS; Chaudhary KR; Stewart DJ
    Circ Res; 2019 Mar; 124(6):822-824. PubMed ID: 30870124
    [No Abstract]   [Full Text] [Related]  

  • 15. Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
    Calcaterra G; Fanos V; Bassareo PP
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30923176
    [No Abstract]   [Full Text] [Related]  

  • 16. EpiHope for the Treatment of Pulmonary Arterial Hypertension: Selective versus Nonselective BET Inhibition.
    Pullamsetti SS; de Jesus Perez VA
    Am J Respir Crit Care Med; 2019 Nov; 200(9):1188-1190. PubMed ID: 31419389
    [No Abstract]   [Full Text] [Related]  

  • 17. Protease-activated receptor 1 as potential therapeutic target in pulmonary arterial hypertension.
    Merkus D; van Beusekom HMM; Boomars KA
    Cardiovasc Res; 2019 Jul; 115(8):1260-1261. PubMed ID: 30903137
    [No Abstract]   [Full Text] [Related]  

  • 18. Response: Still puzzling about a clear definition of pulmonary arterial hypertension in newborns.
    Rosenzweig EB; Abman SH; Berger RMF
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30923178
    [No Abstract]   [Full Text] [Related]  

  • 19. Endothelial CFTR dysfunction and its involvement in the pathogenesis of pulmonary arterial hypertension.
    Declercq M; Treps L; Bousfia S; Carmeliet P; Witters P
    Eur Respir J; 2021 Aug; 58(2):. PubMed ID: 34385264
    [No Abstract]   [Full Text] [Related]  

  • 20. Finding the needle in the haystack: BMP9 and 10 emerge from the genome in pulmonary arterial hypertension.
    Morrell NW
    Eur Respir J; 2019 Mar; 53(3):. PubMed ID: 30872557
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.